Information  X 
Enter a valid email address

Company Name matching 'Immunicum AB'

Date
Time Source
Company
Announcement
21 Sep 2020 7:50 am GNW   Immunicum AB Immunicum AB: Invitation to Corporate Update Event
17 Sep 2020 8:00 am GNW   Immunicum AB Immunicum AB (publ) Presents Preclinical Data on Ilixadencel in Combination with Cancer Therapies and Immunotherapies at the 2020 Virtual ESMO Congress
14 Sep 2020 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Publication of Abstract for the ESMO Virtual Congress 2020
28 Aug 2020 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces the Appointment of Sven Rohmann as Chief Executive Officer
16 Jun 2020 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Gastrointestinal Stromal Tumors (GIST) in Cancer Immunology, Immunotherapy
15 Jun 2020 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Advancement to a Non-Staggered Inclusion Phase in the Phase Ib/II ILIAD Combination Trial
13 May 2020 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Appointment of Peter Hein as Interim Chief Financial Officer
30 Mar 2020 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Peter Suenaert to Resume Role as Chief Medical Officer
03 Feb 2020 10:00 pm GNW   Immunicum AB Immunicum AB (publ) Announces Publication of Abstracts for the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
20 Dec 2019 7:55 am GNW   Immunicum AB Immunicum AB (publ) Announces Upcoming Oral Presentation on MERECA Trial at the ASCO-SITC Clinical Immuno-Oncology Symposium
21 Oct 2019 9:30 am GNW   Immunicum AB Immunicum AB (publ) Announces Positive Preclinical Data on Ilixadencel in Combination with CTLA-4 Immune Checkpoint Inhibitor
01 Oct 2019 12:00 pm GNW   Immunicum AB Immunicum AB (publ) Announces Advancement to Next Dosage Group Level in Phase Ib/II ILIAD Combination Trial
12 Jun 2019 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Positive Topline Results from the Phase I/II Clinical Trial in GIST
28 May 2019 10:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Outcome of Subscription in Employee Incentive Program 2019/2022
07 May 2019 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Upcoming Conferences in May and June
22 Mar 2019 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Upcoming Conferences in March and April
11 Feb 2019 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces First Patient Treated in Phase Ib/II ILIAD Combination Trial
01 Feb 2019 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Upcoming Investor Events in February
22 Jan 2019 7:30 am GNW   Immunicum AB Immunicum AB (publ) Announces Upcoming Investor Events in January
21 Jan 2019 7:30 am GNW   Immunicum AB Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Advanced Hepatocellular Carcinoma in Frontiers in Oncology
24 Oct 2018 11:00 am GNW   Immunicum AB Immunicum AB: Invitation to Investor Events in Gothenburg and Stockholm
22 Oct 2018 3:00 pm GNW   Immunicum AB Immunicum AB (publ) Announces Upcoming Investor Events in October and November
  11:45 am GNW   Immunicum AB Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018
27 Sep 2018 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Upcoming Presentations at Conferences in October
17 Sep 2018 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Appointment of Pawel Kalinski and Inge Marie Svane to Scientific Advisory Board
13 Aug 2018 7:00 am GNW   Immunicum AB Immunicum AB (publ) to Present Preclinical Data on Ilixadencel in Combination with CPIs and Immune Enhancers at ESMO 2018 Congress
18 Jun 2018 1:00 pm GNW   Immunicum AB Immunicum AB (publ) Announces Publication of Scientific Review of Ilixadencel Approach in Pharmaceutical Research
24 May 2018 7:00 am GNW   Immunicum AB Immunicum AB: Invitation to Investor Event
14 May 2018 11:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in May and June
03 Apr 2018 7:00 am GNW   Immunicum AB Immunicum AB (publ) Provides Update on Ilixadencel Clinical Development Program
21 Mar 2018 1:00 pm GNW   Immunicum AB Immunicum AB: Invitation to Investor Events
20 Mar 2018 7:00 am GNW   Immunicum AB Immunicum AB: Immunicum AB (publ) Announces ATMP Certificate Granted by EMA to Ilixadencel for Manufacturing Quality and Non-clinical Data
05 Feb 2018 7:00 am GNW   Immunicum AB Immunicum AB (publ) Presents Case Study of One Patient from Phase I/II HCC Trial at Cholangiocarcinoma Foundation Annual Conference
22 Jan 2018 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in January and February
15 Jan 2018 7:45 am GNW   Immunicum AB Immunicum AB (publ) Initiates Trading of Shares on Nasdaq Stockholm
22 Nov 2017 7:00 am GNW   Immunicum AB Immunicum AB: Invitation to Investor Events
10 Nov 2017 11:00 am GNW   Immunicum AB Immunicum AB (publ) and Academic Collaborators Publish Preclinical Ilixadencel Mode of Action Data in Journal Oncoimmunology
07 Nov 2017 1:01 pm GNW   Immunicum AB Immunicum AB (publ) Presents Further Preclinical Ilixadencel Mode of Action Data at Annual SITC Meeting
10 Oct 2017 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Appointment of Sharon Longhurst as Head of CMC
09 Oct 2017 11:00 am GNW   Immunicum AB Immunicum AB (publ) Announces the Nomination Committee for AGM 2018
21 Sep 2017 7:00 am GNW   Immunicum AB Immunicum AB (publ) to Present Preclinical Data on Ilixadencel's Mode of Action at the SITC Meeting in the US
22 Aug 2017 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Upcoming Presentations at Conferences in August and September
15 Aug 2017 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Last Patient Last Visit in the Ongoing Phase I/II Hepatocellular Carcinoma Study
10 Aug 2017 7:00 am GNW   Immunicum AB Immunicum AB (publ) Announces Enrollment of First United States Patient in the Ongoing Phase 2 MERECA Trial for Ilixadencel


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t